Lv1
60 积分 2025-11-24 加入
Olaparib and Durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA)
1小时前
待确认
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial
2天前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
3个月前
已完结
High-risk MCL: recognition and treatment
6个月前
已完结
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE
7个月前
已完结
皖公网安备34019202002308
